David Rouquié

David Rouquié

Auto-generated profile, based on publicly available information

David Rouquié

Toxicology Data Science

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2025 in Chemical Research in Toxicology
Verified
Journal Article
Open access
SSSrijit Seal
Srijit Seal
MMManas Mahale
Manas Mahale
MGMiguel García-Ortegón
Miguel García-Ortegón
CJChaitanya K. Joshi
Chaitanya K. Joshi
LHLayla Hosseini-Gerami
Layla Hosseini-Gerami
ABAndreas Bender
Andreas Bender
Machine learning (ML) is increasingly valuable for predicting molecular properties and toxicity in drug discovery. However, toxicity-related end points have always been challenging to evaluate experimentally with respect to in vivo translation due to the required resources for human and animal studies; this has impacted data availability in the field. ML can augment or even potentially replace traditional experimental processes depending on the project phase and specific goals of the prediction. For instance, models can be used to select promising compounds for on-target effects or to deselect those with undesirable characteristics (e.g., off-target or ineffective due to unfavorable pharmacokinetics). However, reliance on ML is not without risks, due to biases stemming from nonrepresentative training data, incompatible choice of algorithm to represent the underlying data, or poor model building and validation approaches. This might lead to inaccurate predictions, misinterpretation of the confidence in ML predictions, and ultimately suboptimal decision-making. Hence, understanding the predictive validity of ML models is of utmost importance to enable faster drug development timelines while improving the quality of decisions. This perspective emphasizes the need to enhance the understanding and application of machine learning models in drug discovery, focusing on well-defined data sets for toxicity prediction based on small molecule structures. We focus on five crucial pillars for success with ML-driven molecular property and toxicity prediction: (1) data set selection, (2) structural representations, (3) model algorithm, (4) model validation, and (5) translation of predictions to decision-making. Understanding these key pillars will foster collaboration and coordination between ML researchers and toxicologists, which will help to advance drug discovery and development.

31 August 2023 in Chemical Research in Toxicology
Verified
Journal Article
Open access
VLVanille Lejal
Vanille Lejal
NCNatacha Cerisier
Natacha Cerisier
DRDavid Rouquié
David Rouquié
OTOlivier Taboureau
Olivier Taboureau
Drug-induced liver injury (DILI) is a significant concern in drug development, often leading to drug withdrawal. Although many studies aim to identify biomarkers and gene/pathway signatures related to liver toxicity and aim to predict DILI compounds, this remains a challenge in drug discovery. With a strong development of high-content screening/imaging (HCS/HCI) for phenotypic screening, we explored the morphological cell perturbations induced by DILI compounds. In the first step, cell morphological signatures were associated with two datasets of DILI chemicals (DILIRank and eTox). The mechanisms of action were then analyzed for chemicals having transcriptomics data and sharing similar morphological perturbations. Signaling pathways associated with liver toxicity (cell cycle, cell growth, apoptosis, ...) were then captured, and a hypothetical relation between cell morphological perturbations and gene deregulation was illustrated within our analysis. Finally, using the cell morphological signatures, machine learning approaches were developed to predict chemicals with a potential risk of DILI. Some models showed relevant performance with validation set balanced accuracies between 0.645 and 0.739. Overall, our findings demonstrate the utility of combining HCI with transcriptomics data to identify the morphological and gene expression signatures related to DILI chemicals. Moreover, our protocol could be extended to other toxicity end points, offering a promising avenue for comprehensive toxicity assessment in drug discovery.

8 February 2019 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
IGIngrid Grenet
Ingrid Grenet
KMKevin Merlo
Kevin Merlo
JCJean-Paul Comet
Jean-Paul Comet
RTRomain Tertiaux
Romain Tertiaux
DRDavid Rouquié
David Rouquié
FDFrédéric Dayan
Frédéric Dayan

7 March 2012 in Experimental and Toxicologic Pathology
Verified
Journal Article
Closed access
CFCéline Ferre
Céline Ferre
Sara BellucoSara Belluco
Sara Belluco
HTHelen Tinwell
Helen Tinwell
RBRémi Bars
Rémi Bars
MBMohamed Benahmed
Mohamed Benahmed
FSFrédéric Schorsch
Frédéric Schorsch

8 November 2024 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
FCFabrice Camilleri
Fabrice Camilleri
JWJoanna M. Wenda
Joanna M. Wenda
CPClaire Pecoraro-Mercier
Claire Pecoraro-Mercier
JCJean-Paul Comet
Jean-Paul Comet
DRDavid Rouquié
David Rouquié